Corcept Therapeutics (NASDAQ: CORT)
Corcept Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Corcept Therapeutics Company Info
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
News & Analysis
Top Biotech ETFs to Buy Now
Here are the five best biotech ETFs to invest in right now.
3 Reasons Why Corcept Therapeutics Is a Better Buy Than Shiba Inu Coin
Making medicines is a more reliable path to share price appreciation than memes.
Why Corcept Therapeutics Stock Was Up 11.6% Friday
Investors may be looking for a bargain after the company was hit with bad news this week.
Why Corcept Therapeutics Tanked by Almost 17% Today
A U.S. attorney is interested in the company for the wrong reasons.
3 Healthcare Stocks That Could Be Millionaire-Makers
With solid revenue growth, these stocks have the potential to more than triple over the next few years.
Why Corcept Therapeutics Soared 37% Higher in September
A patent decision on its cortisol therapy Korlym is expected to be rendered next month.
2 Monster Stocks in the Making
These two biotechs have the potential to become giants within their domains.
Should You Climb on Board the Corcept Therapeutics Train?
This biotech company has seen huge growth over the past five years.
Valuation
Earnings Transcripts
Corcept Therapeutics (CORT) Q2 2022 Earnings Call Transcript
CORT earnings call for the period ending June 30, 2022.
Corcept Therapeutics (CORT) Q1 2022 Earnings Call Transcript
CORT earnings call for the period ending March 31, 2022.
Corcept Therapeutics (CORT) Q4 2021 Earnings Call Transcript
CORT earnings call for the period ending December 31, 2021.
Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript
CORT earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.